Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling

Lirong Peng* email, Xiaofang Xing* email, Weijun Li* email, Like Qu email, Lin Meng email, Shenyi Lian email, Beihai Jiang email, Jian Wu email and Chengchao Shou email

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, PR China

author email corresponding author email* Contributed equally

Molecular Cancer 2009, 8:110doi:10.1186/1476-4598-8-110

Published: 24 November 2009

Additional files

Additional file 1:

Western blot analysis of PRL-3 protein in LoVo cells. LoVo-C and LoVo-P cells were treated with 2 μm Adriamycin or DMSO for 12 h, then cells were harvested and cell lysates (50 μg of protein) were subjected to Western blot with antibodies against PRL-3 (Sigma), Myc, p53 (DO-1, Santa Cruz), and GAPDH, respectively. Antibody to PRL-3 recognized exogenous PRL-3, but no endogenous PRL-3 was detected in both cell lines. LoVo-P cells had more p53 expression, which was consistent with results from Basak et al [Ref [23]].

Format: TIFF Size: 430KB Download file

Additional file 2:

Wound healing assay. The effect of PRL-3 on the motilities of LoVo cells analyzed with wound healing assay for 72 h and the closure of the wound line was recorded every 24 h.

Format: TIFF Size: 1.7MB Download file

Additional file 3:

Correlation between Expression of PRL-3 and P-ERK1/2 in Human Colon Cancer Tissues. File shows the correlation between expression of PRL-3 and P-ERK1/2 in human colon cancer tissues.

Format: DOC Size: 30KB Download file

This file can be viewed with: Microsoft Word Viewer


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.